Lee Young-Mi, Song Inmyung, Lee Eui-Kyung, Shin Ju-Young
Int J Clin Pharmacol Ther. 2017 Oct;55(10):781-790. doi: 10.5414/CP203072.
This descriptive study analyzed the scale of first- and second-generation antihistamine prescription in elderly outpatients in Korea and the characteristics associated with this prescription.
We conducted a drug utilization study using the Korea Health Insurance Review and Assessment Service-Aged Patient Sample (HIRA-APS) database from January 1 to December 31, 2013. The study subjects were elderly outpatients aged 65 years and older who were prescribed antihistamines. The study drugs included 6 first-generation and 16 second-generation antihistamines. The prescription pattern of first-generation antihistamines was based on region, diagnosis, and clinical specialty. Multivariate logistic regression analysis was used to determine the factors associated with first-generation antihistamine prescription. Odds ratios (ORs) with 95% confidence interval (CI) were calculated.
A total of 1,152,556 elderly outpatients were identified as having visited various medical facilities in 2013, of which 23.4% received at least one prescription for first-generation antihistamine monotherapy. First-generation antihistamines were more likely to be prescribed in secondary care hospitals (OR = 1.74; 95% CI 1.69 - 1.78) than in tertiary care hospitals, and in urban areas (OR = 1.21; 95% CI 1.20 - 1.21) than in the Seoul metropolitan area. First-generation antihistamines were also more likely to be prescribed for treating the common cold (OR = 1.06; 95% CI 1.05 - 1.06) than any other disease.
CONCLUSION: A large proportion (23.4%) of elderly outpatients in Korea received prescriptions for first-generation antihistamines. Efforts to reduce prescriptions of first-generation antihistamines are recommended, especially prescriptions associated with common cold diagnosis in secondary care hospitals and in urban areas. .
本描述性研究分析了韩国老年门诊患者第一代和第二代抗组胺药的处方规模以及与此类处方相关的特征。
我们利用韩国健康保险审查与评估服务-老年患者样本(HIRA-APS)数据库,对2013年1月1日至12月31日期间的数据进行了药物利用研究。研究对象为65岁及以上且开具了抗组胺药处方的老年门诊患者。研究药物包括6种第一代抗组胺药和16种第二代抗组胺药。第一代抗组胺药的处方模式基于地区、诊断和临床专科。采用多因素逻辑回归分析来确定与第一代抗组胺药处方相关的因素。计算了比值比(OR)及95%置信区间(CI)。
2013年共有1,152,556名老年门诊患者被确定曾就诊于各类医疗机构,其中23.4%接受过至少一次第一代抗组胺药单药治疗的处方。与三级医疗机构相比,二级医疗机构更有可能开具第一代抗组胺药(OR = 1.74;95% CI 1.69 - 1.78),与首尔都市区相比,城市地区更有可能开具第一代抗组胺药(OR = 1.21;95% CI 1.20 - 1.21)。与治疗其他任何疾病相比,第一代抗组胺药也更有可能用于治疗普通感冒(OR = 1.06;95% CI 1.05 - 1.06)。
韩国很大比例(23.4%)的老年门诊患者接受了第一代抗组胺药的处方。建议努力减少第一代抗组胺药的处方,尤其是二级医疗机构和城市地区与普通感冒诊断相关的处方。